SCHOLARLY PUBLICATION ✓ Open Access

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

Ronald Boellaard, Mike J. O’Doherty, Wolfgang Weber, Felix Manuel Mottaghy, Markus Nowak Lonsdale, Sigrid G. Stroobants, Wim J.G. Oyen, Joerg Kotzerke, Otto S. Hoekstra, Jan Pruim, Paul K. Marsden, Klaus Tatsch, Corneline J. Hoekstra, Eric P. Visser, Bertjan Arends, Fred J. Verzijlbergen, Josée M. Zijlstra, Emile F.I. Comans, Adriaan A. Lammertsma, Anne M. J. Paans, Antoon T. M. Willemsen, Thomas Beyer, Andreas Bockisch, Cornelia M. Schaefer‐Prokop, Dominique Delbeke, Richard Paul Baum, Arturo Chiti, Bernd Joachim Krause

📖 European Journal of Nuclear Medicine and Molecular Imaging → 📅 2009-11-13 🔗 DOI: 10.1007/s00259-009-1297-4

View Journal Profile → ⬇ Download PDF View Official Paper ↗

📄 Abstract

The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will therefore address general information about[18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out,interpret, and document quantitative FDG PET/CT examinations,but will concentrate on the optimisation of diagnostic quality and quantitative information.

ℹ️ Publication Details

Journal: European Journal of Nuclear Medicine and Molecular Imaging
Published: 2009-11-13
DOI: 10.1007/s00259-009-1297-4
OpenAlex: W2145938281
Access: ✓ Open Access

📄 Abstract

📤 Share this page

🔬 Related Research Papers

The EANM practice guidelines for bone scintigraphy

FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC

Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer